Valvoline™ Global, The Original Motor Oil, Accelerates Growth in Asia Pacific with Horse Powertrain Collaborations
The expansion secures Valvoline Global as Geely's official lubricant technology partner, integrating its advanced fluids into factory-fill production and a newly launched aftersales network. SINGAPORE and SYDNEY, July 15, 2026 /PRNewswire/ --...
From permanent circuits to street circuits, Geely Cyan Racing secures fifth victory of the 2026 Kumho FIA TCR World Tour
VILA REAL, Portugal, July 15, 2026 /PRNewswire/ -- The European rounds of the 2026 Kumho FIA TCR World Tour concluded in Vila Real, where Geely Cyan Racing secured its fifth victory of the season and took the lead in the Teams' Championship. French...
Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer
HONG KONG, July 14, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that it has entered into a collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) to advance a Phase II clinical study evaluating a...
THE HONG KONG JOCKEY CLUB CELEBRATES THE FINAL EIGHT WITH "EIGHT TO GLORY, PRESENTED BY LENOVO"
LINK TO REAL TIME IMAGES AND VIDEOS HERE. HONG KONG, July 9, 2026 /PRNewswire/ -- On Wednesday, July 8 at Happy Valley, The Hong Kong Jockey Club (the Club) presented a special race to capture a singular cultural moment: where the world's love of...
ICAC Commissioner attends first IAACA European regional anti-corruption conference in Hungary
BUDAPEST, Hungary, July 2, 2026 /PRNewswire/ -- ICAC Commissioner, Mr Woo Ying-ming, in his capacity of President of the International Association of Anti-Corruption Authorities (IAACA), successfully concluded the first European regional...
Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Herui's budesonide enteric capsules
SHANGHAI, June 24, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...
Abbisko Therapeutics Deepens R&D Collaboration with Lilly
SHANGHAI, June 24, 2026 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) today announced that it has entered into a strategic research collaboration and license agreement with Eli Lilly and...
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
HANGZHOU, China, SHANGHAI and BOSTON, June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseases, today announced a...
Nature's Miracle Holding Inc Reports Q1 2026 Net Income of $2.8 Million with Fully Diluted EPS of $0.01 and Strategic Expansion into U.S. Advanced Contract Manufacturing for Drone and AI Data Center
ONTARIO, Calif., May 28, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. ("Nature's Miracle" or the "Company") (OTCID: NMHI), a leader in controlled environment agriculture, vertical farming and infrastructure solutions, today announced financial...
U Power Hydro Data Joint Venture Secures Thailand Data Center Energy Project 3MW Pilot for Planned 100MW Deployment
BANGKOK, Thailand, May 27, 2026 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) ("U Power" or the "Company"), a provider of AI-integrated solutions for next-generation energy grids and intelligent transportation systems, building on its proprietary...